首页> 美国卫生研究院文献>PLoS Clinical Trials >Steered Molecular Dynamics Simulations Reveal the Likelier Dissociation Pathway of Imatinib from Its Targeting Kinases c-Kit and Abl
【2h】

Steered Molecular Dynamics Simulations Reveal the Likelier Dissociation Pathway of Imatinib from Its Targeting Kinases c-Kit and Abl

机译:指导的分子动力学模拟从其靶向激酶c-Kit和Abl揭示了伊马替尼的可能解离途径

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Development of small molecular kinase inhibitors has recently been the central focus in drug discovery. And type II kinase inhibitors that target inactive conformation of kinases have attracted particular attention since their potency and selectivity are thought to be easier to achieve compared with their counterpart type I inhibitors that target active conformation of kinases. Although mechanisms underlying the interactions between type II inhibitors and their targeting kinases have been widely studied, there are still some challenging problems, for example, how type II inhibitors associate with or dissociate from their targeting kinases. In this investigation, steered molecular dynamics simulations have been carried out to explore the possible dissociation pathways of typical type II inhibitor imatinib from its targeting protein kinases c-Kit and Abl. The simulation results indicate that the most favorable pathway for imatinib dissociation corresponds to the ATP-channel rather than the relatively wider allosteric-pocket-channel, which is mainly due to the different van der Waals interaction that the ligand suffers during dissociation. Nevertheless, the direct reason comes from the fact that the residues composing the ATP-channel are more flexible than that forming the allosteric-pocket-channel. The present investigation suggests that a bulky hydrophobic head is unfavorable, but a large polar tail is allowed for a potent type II inhibitor. The information obtained here can be used to direct the discovery of type II kinase inhibitors.
机译:小分子激酶抑制剂的开发最近已成为药物发现的中心焦点。而且,靶向激酶失活构象的II型激酶抑制剂引起了特别关注,因为与靶向激酶活性构象的相应I型抑制剂相比,它们的效价和选择性被认为更容易实现。尽管已经广泛研究了II型抑制剂与其靶向激酶之间相互作用的潜在机制,但仍然存在一些具有挑战性的问题,例如II型抑制剂如何与其靶向激酶结合或分离。在这项研究中,进行了分子动力学模拟研究,以探讨典型II型抑制剂伊马替尼与其靶向蛋白激酶c-Kit和Abl的可能解离途径。模拟结果表明,伊马替尼解离的最有利途径对应于ATP通道,而不是相对较宽的变构口袋通道,这主要是由于配体在解离过程中遭受的范德华相互作用不同。然而,直接原因是由于构成ATP通道的残基比形成变构口袋通道的残基更灵活。目前的研究表明,笨重的疏水头是不利的,但是强力的II型抑制剂可以使用较大的极性尾巴。此处获得的信息可用于指导II型激酶抑制剂的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号